Therapy News and Research

RSS

Breakthrough method allows stem cell treatment for critically ill patients on ECMO

A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández University of Elche (UMH, Spain) has developed a new method to deliver cell therapies in patients on extracorporeal membrane oxygenation (ECMO), a life support system used in cases of severe lung failure.

16 Apr 2025

Male survivors of intimate partner violence struggle with isolation and stigma

Men experiencing intimate partner violence turn to harmful coping strategies due to limited services and persistent social stigma, according to a new Simon Fraser University study.

16 Apr 2025

Early menopause linked to worse cognitive function in later life

A team of researchers from the Tohoku University Graduate School of Medicine and Tokyo Metropolitan Institute of Medical Science found that women who entered menopause before the age of 40 had worse cognitive outcomes than women who entered menopause after the age of 50.

16 Apr 2025

Nature based activities improve mental health in just twelve weeks

Researchers evaluating a nature-based programme of activities for patients with mild to moderate mental health conditions have shown that improvements in mood and anxiety levels can be seen in as little as 12 weeks.

16 Apr 2025

Music therapy intervention improves mental health for heart failure and COPD patients

A new study from University Hospitals Connor Whole Health found that it was feasible to conduct a hybrid music therapy intervention for patients with heart failure and patients with chronic obstructive pulmonary disease (COPD).

16 Apr 2025

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making it more accessible and efficient.

16 Apr 2025

Early combination treatment can prevent heart attacks and save lives

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all.

16 Apr 2025

Promising findings for the treatment of patients with pulmonary arterial hypertension with a high risk of mortality

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, sotatercept.

16 Apr 2025

Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has signed an exclusive distribution agreement with MineBio, a leading Chinese supply chain and logistics organization

From Atelerix Ltd 16 Apr 2025

Gut bacteria turn bile acids into allies against cancer

Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling, according to a preclinical study led by Weill Cornell Medicine investigators.

16 Apr 2025

Blood test for tumor DNA may predict melanoma recurrence

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.

15 Apr 2025

Study reveals a potential breakthrough in treating osteonecrosis of the femoral head

A recent study has uncovered a potential breakthrough in treating osteonecrosis of the femoral head (ONFH), a debilitating bone disease that causes severe pain and joint collapse.

15 Apr 2025

UVA scientist secures funding to use sound waves for breast cancer therapy

University of Virginia researcher Natasha D. Sheybani, PhD, has received $5.5 million from the federal Department of Defense to support her cutting-edge efforts to use focused sound waves to improve our immune system's ability to battle breast cancer.

15 Apr 2025

Reserpine shows promise in treating retinitis pigmentosa in rat studies

New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa.

15 Apr 2025

Inherited genetic variants play crucial role in cancer development and behavior

A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the National Cancer Institute-funded Clinical Proteomic Tumor Analysis Consortium (CPTAC) and colleagues around the world, has discovered that the genes we are born with-known as germline genetic variants-play a powerful, underappreciated role in how cancer develops and behaves.

15 Apr 2025

Afternoon could be best time for asthma inhaler, study shows

A mid-afternoon puff could be the best way to get the most out of your asthma inhaler according to a new study led by University of Manchester researchers.

15 Apr 2025

Deportation fears add to mental health problems confronting Colorado resort town workers

When Adolfo Román García-Ramírez walks home in the evening from his shift at a grocery store in this central Colorado mountain town, sometimes he thinks back on his childhood in Nicaragua.

15 Apr 2025

#RareDiseases - The EU Action Plan must step up European-national cooperation

A high-level conference convened in Warsaw under the auspices of the Polish Presidency of the Council of the European Union highlighted the importance of adopting a comprehensive Europe-wide policy framework on rare diseases.

15 Apr 2025

Lithium shifts circadian rhythms early in bipolar disorder and may offer clues to treatment response

A randomized controlled trial shows that lithium treatment in bipolar disorder patients reduces daytime activity, advances its onset time, and increases volatility in circadian rest-activity patterns. These changes appear early and independently of mood, offering promise as early biomarkers of treatment response.

14 Apr 2025

Early combination therapy after heart attack reduces risk of recurrence and death

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute event.

14 Apr 2025

Therapy News and Research

Breakthrough method allows stem cell treatment for critically ill patients on ECMO

Male survivors of intimate partner violence struggle with isolation and stigma

Early menopause linked to worse cognitive function in later life

Nature based activities improve mental health in just twelve weeks

Music therapy intervention improves mental health for heart failure and COPD patients

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Early combination treatment can prevent heart attacks and save lives

Promising findings for the treatment of patients with pulmonary arterial hypertension with a high risk of mortality

Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Gut bacteria turn bile acids into allies against cancer

Blood test for tumor DNA may predict melanoma recurrence

Study reveals a potential breakthrough in treating osteonecrosis of the femoral head

UVA scientist secures funding to use sound waves for breast cancer therapy

Reserpine shows promise in treating retinitis pigmentosa in rat studies

Inherited genetic variants play crucial role in cancer development and behavior

Afternoon could be best time for asthma inhaler, study shows

Deportation fears add to mental health problems confronting Colorado resort town workers

#RareDiseases - The EU Action Plan must step up European-national cooperation

Lithium shifts circadian rhythms early in bipolar disorder and may offer clues to treatment response

Early combination therapy after heart attack reduces risk of recurrence and death

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News